Conference abstracts

* = presenting author.

ORAL PRESENTATIONS

Otter JA*, Mookerjee S, Davies F, Galletly T, Brannigan E, Holmes A. Evaluating the impact of enhanced infection prevention measures in reducing CPE clinical infections. Infection Prevention Society (IPS) Annual Meeting 2018, Glasgow, Scotland, 30 Sept – 2 Oct 2018.

Otter JA*, Natale A, Batra R, Tosas Auguet O, Dyakova E, Goldenberg SD, Edgeworth JD. Individual and community-based risk factors for ESBL Enterobacteriaceae colonization identified by universal admission screening in London. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid, Spain, 21-24 April 2018.

Knight GM, Dyakova E, Mookerjee S, Davies F, Brannigan ET, Otter JA, Holmes AH. Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid, Spain, 21-24 April 2018.

Dyakova E*, Mookerjee S, Alexander M, Donaldson H, Bishop H, Owens D, Bleeze G, Ghazy A, Bamford K, Otter JA. Using a stand-alone air disinfection unit to reduce the risk from contaminated aerosols from heater-cooler units used for cardiothoracic surgery. Infection Prevention Society (IPS) Annual Meeting 2017, Manchester, UK, 18-20 September 2017.

Otter JA*, Burgess P, Davies F, Mookerjee S, Gilchrist M, Parsons D, Brannigan ET, Robotham JV, Holmes AH. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective. Healthcare Infection Society (HIS), Edinburgh, Scotland, 6-8 November 2016.

Mookerjee S*, Dyakova E, Davies F, Bamford K, Galletly T, Brannigan E, Holmes AH, Otter JA. Managing repeated screening for known CPE carriers: once positive always positive? Infection Prevention Society (IPS) Annual Meeting. Harrogate, UK, 26-28 September 2016.

Mookerjee S, Dyakova E, Davies F, Bamford K, Brannigan E, Holmes A, Otter JA*. Screening for CPE: sensitivity of multiple admission screens. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, The Netherlands, 9-12 April 2016.

Brannigan E*, Otter JA, Davies F, Mookerjee S, Dyakova E, Bamford K, Donaldson H, Nelson D, Galletly T, Gilchrist M, Holmes A. Responding to an outbreak of CPE: learning points from the front line. Federation of Infection Sciences (FIS) Annual Meeting. Glasgow, Scotland, 21-23 Nov 2015.

Otter JA*, Dyakova E, Bisnauthsing K, Querol-Rubiera A, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth J, Goldenberg S. Who’s carrying CRE? Universal admission screening in London. Infection Prevention Society (IPS) Annual Meeting. Liverpool, UK, 28-30 September 2015.

Dyakova E*, Bisnauthsing K, Querol-Rubiera A, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth J, Goldenberg S, Otter JA. “Can I swab your rectum, please?”: Improving compliance with rectal screening for CRE. Infection Prevention Society (IPS) Annual Meeting. Liverpool, UK, 28-30 September 2015.

Mookerjee S*, Sullivan J, Davies F, Donaldson H, Brannigan E, Holmes A, Otter JA. Risk factors for patients with carbapenemase-producing Enterobacteriaceae (CPE) in a Northwest London hospital Trust, 2014 – 2015. Infection Prevention Society (IPS) Annual Meeting. Liverpool, UK, 28-30 September 2015.

Fisher D*, Pang L, Salmon S, Teo C, Cook A, Otter JA. Where’s all the VRE gone? A successful VRE bundle at a Singapore hospital. International Congress of the Asia Pacific Society of Infection Control. Taipei, Taiwan, 26-29 March 2015.

O’Halloran P, Otter JA, Adams NMT, Chewins J*. Improvements in pain, odour, sleep and social activities for patients with chronic wounds using novel aqueous oxygen peroxide (AOP) technology. Infection Prevention Society (IPS) Annual Meeting. Glasgow, Scotland, 29 September – 1 October 2014.

Keward J*, Bradshaw P, Otter JA. Reducing the number of missed isolation days in the Alder Hey High Dependency Unit using the Bioquell Pod. Infection Prevention Society (IPS) Annual Meeting. Glasgow, Scotland, 29 September – 1 October 2014.

Hughes J*, Stabler R, Karadag T, Desai N, Patel A, Otter JA, Edgeworth JD, Tosas-Auguet O. Selection of low-level mupirocin resistance in hospital but not community MRSA clones. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Barcelona, Spain, 10-13 May 2014

Marbach H, Boakes E, Lynham S, Ward M, Otter JA*, Edgeworth JD. Identification of a distinctive virulence phenotype for endocarditis-associated clonal complex 22 MRSA isolates with reduced vancomycin susceptibility. ID Week, San Francisco, California, USA, 2-6 October 2013.

Otter JA*, Tosas O, Herdman MT, Williams B, Tucker D, Edgeworth JD, French GL. Targeted MRSA admission screening would fail to identify almost half of carriers in a London Hospital. Infection Prevention Society (IPS) Annual Meeting. London, UK, 30 September – 2 October 2013.

Batra R, Halligan E, Cliff P, Otter JA, Edgeworth JD*. Selection of qacA carriage in MRSA clonal complex 22 but not 30 during a successful infection control programme incorporating chlorhexidine-based decolonisation. 21st Annual Meeting of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Milan, Italy, 7-10 May 2011.

Otter JA*, Duclos M, Salkeld JAG, Nowakowski E, Passaretti CL, Perl TM. Decontamination of unused, packaged supplies contaminated with vancomycin-resistant enterococci (VRE) using hydrogen peroxide vapor (HPV). 5th Decennial Meeting of the Society for Healthcare Epidemiology of America (SHEA), Atlanta, GA, USA, 2010. Abstract 62. (Also presented at the Birmingham International Burns Congress, 5-7 September 2010, Birmingham UK. Poster Abstract 13.)

Otter JA*, Ellington MJ, Kearns AM, French GL. Panton-Valentine leukocidin gene sequence and the PVL-encoding bacteriophage vary with lineage in community-associated methicillin-resistant Staphylococcus aureus. 19th Annual Meeting of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Helsinki, Finland, 2009.

Otter JA*, Passaretti CL, Ross T, Carroll KC, French GL, Perl TM. Low frequency of environmental contamination with methicillin-resistant Staphylococcus aureus in an inner city emergency department and outpatient HIV clinic. 19th Annual Meeting of the Society for Healthcare Epidemiology of America (SHEA). San Diego, CA, USA, 2009.

Otter JA*, Davies B, Klein J, Watts T, Kearns AM, French GL. Identification and control of an outbreak of gentamicin-resistant, methicillin-susceptible Staphylococcus aureus on a neonatal unit. 13th International Symposium on Staphylococci and Staphylococcal Infection (ISSSI), Cairns, Australia, 2008.

Otter JA*, Cummins M, Ahmad F, van Tonder C, Drabu Y. O19 Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. Int J Antimicrob Agents 2007;29 Suppl. 2:S4. (16th Annual Meeting of the European Congress of Clinical Microbiology and Infectious Disease (ECCMID))

Boyce JM*, Havill NL, Otter JA, McDonald LC, Adams NM, Thompson A, Wiggs L, Noble-Wang J. Impact of hydrogen peroxide vapor room bio-decontamination on environmental contamination and nosocomial transmission of Clostridium difficile. 16th Annual Meeting of the Society for Healthcare Epidemiology of America (SHEA), Chicago, Illinois, 2006. Abstract 155.

Otter JA*, Havill NL, Adams NMT, Boyce JM. Extensive environmental contamination associated with patients with loose stools and methicillin-resistant Staphylcococcus aureus (MRSA) colonization of the gastrointestinal tract. 16th Annual Meeting of the Society for Healthcare Epidemiology of America (SHEA), Chicago, Illinois, 2006. Abstract 159.

POSTERS

Galletly T, Singleton J, Alexander M, Samarasinghe D, Ghazy A, Holmes A, Brannigan E, Otter JA*. Are our attempts to control CPE going down the drain? Infection Prevention Society (IPS) Annual Meeting 2018, Glasgow, Scotland, 30 Sept – 2 Oct 2018.

Singleton J, Galletly T, Mookerjee S, Holmes A, Mumbwatasai J, Cummings N, Pastrana M, Bicknell C, Hathway K, Otter JA*. Semi-permanent single room ‘pods’: a solution to reduce lost bed days? Infection Prevention Society (IPS) Annual Meeting 2018, Glasgow, Scotland, 30 Sept – 2 Oct 2018.

Mookerjee S, Dyakova E, Davies F, Holmes AH, Otter JA*Risk factors for carbapenem-resistant Enterobacteriaceae (CRE) carriage at the time of hospital admission.  European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid, Spain, 21-24 April 2018.

Otter JA*, Galletly T, Davies F, Hitchcock J, Dyakova E, Mookerjee S, Holmes A, Brannigan E. Planning to halve GNBSI: getting to grips with healthcare-associated E. coli BSI sources. Infection Prevention Society (IPS) Annual Meeting 2017, Manchester, UK, 18-20 September 2017.

Mookerjee S*, Davies F, Dyakova E, Galletly T, Holmes A, Otter JA. Promiscuous plasmids? Scaling infection control implications of horizontal spread of carbapenemase genes between species. Infection Prevention Society (IPS) Annual Meeting 2017, Manchester, UK, 18-20 September 2017.

Dyakova E*, Mookerjee S, Hitchcock J, Brannigan E, Davies F, Galletly T, Holmes A, Otter JA. MRSA admission prevalence and in-hospital acquisition in a large London teaching hospital. Infection Prevention Society (IPS) Annual Meeting 2017, Manchester, UK, 18-20 September 2017.

Hitchcock J*, Dyakova E, Mookerjee S, Otter JA, Galletly T. Is 5 better than 1? Moving from auditing 1 to all 5 WHO hand hygiene moments. Infection Prevention Society (IPS) Annual Meeting 2017, Manchester, UK, 18-20 September 2017.

Hitchcock J*, Liu M, Rodrigues E, Del Mundo A, O’Gara S, Ryan L, Otter JA, Mookerjee S, Dyakova E. Point prevalence survey of vascular access devices and associated complication, and urinary catheters. Infection Prevention Society (IPS) Annual Meeting 2017, Manchester, UK, 18-20 September 2017.

Otter JA*, Natale A, Batra R, Dyakova E, Goldenberg SD, Edgeworth JD. Prevalence, risk factors, and the genetic basis of ESBL Enterobacteriaceae identified by universal admission screening: ESBL winging its way around the world. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, 22-25 April 2017.

Dyakova E, Mookerjee S, Davies F, Brannigan E, Gilchrist M, Holmes A, Otter JA, Costelloe C. Analysis of the risk factors associated with an outbreak of NDM-producing CPE in a London hospital. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, 22-25 April 2017.

Goldenberg SD, Batra R, Otter JA*, Edgeworth JD. Cost utility analysis of alternative Carbapenemase Producing Enterobacteriaceae (CPE) screening strategies in a low prevalence setting. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, 22-25 April 2017.

Batra R, Natale A, Otter JA, Bisnauthsing K, Goldenberg S, Patel A, Querol-Rubiera A, Edgeworth JD. Use of Check-Points Check-MDR microarray for investigating resistance genes among Enterobacteriaceae in South London. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, 22-25 April 2017.

Sullivan J, Dyakova E, Mookerjee S, Davies F, Galletly T, Brannigan E, Gilchrist M, Holmes AH, Otter JA*. How much do we Trust epidemiological definitions of healthcare-associated C. difficile infection? Healthcare Infection Society (HIS), Edinburgh, Scotland, 6-8 November 2016.

Mookerjee S, Martin K, Atucha-Zambrano I, Corbin N, Galletly T, Brannigan E, Holmes AH, Otter JA*. Measuring and improving compliance with risk-factor based CPE admission screening. Infection Prevention Society (IPS) Annual Meeting. Harrogate, UK, 26-28 September 2016.

Galletly T, Brannigan E, Mookerjee S, Davies F, Holmes AH, Otter JA*. Detecting and managing CPE outbreaks: seek and you shall find. Infection Prevention Society (IPS) Annual Meeting. Harrogate, UK, 26-28 September 2016.

Alexander M, Ghazy A, Bamford K, Brannigan E, Donaldson H, Bishop H, Otter JA*. Reducing SSI risk from water heater/coolers units in cardiothoracic surgery. Infection Prevention Society (IPS) Annual Meeting. Harrogate, UK, 26-28 September 2016.

Otter JA*, Gilchrist M, Brannigan E, Davies F, Donaldson H, Bamford KB, Hill R, Doumith M, Turton J, Hopkins K, Woodford M, Holmes AH. Emergence and clonal spread of colistin resistance during an outbreak of CPE in London. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, The Netherlands, 9-12 April 2016.

Moore LSP*, Freeman R, Charlett A, Otter JA, Donaldson H, Holmes AH. Refining national surveillance algorithms to facilitate local outbreak detection of carbapenem-resistant organisms. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, The Netherlands, 9-12 April 2016.

Shibu P, Dronavalli J, Rebec M, Goonesekera S, Mookerjee S, Otter JA, Donaldson H, Davies F. Evaluation of different media for introduction of a CPE screening program at a UK hospital. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, The Netherlands, 9-12 April 2016.

Eades C, Davies F, Donaldson H, Ghazy A, Kadhani T, Otter JA, Brannigan E, Hopkins K, Hill R, Turton J, Pavlu J, Mookherjee S, Woodford N, Holmes AH. Outbreak of GES-5 carbapenemase-producing Klebsiella oxytoca in a London haematology unit. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, The Netherlands, 9-12 April 2016.

Moore LSP*, Freeman R, Charlett A, Otter JA, Donaldson H, Holmes AH. Real-time antimicrobial resistance surveillance in critical care: identifying outbreaks of carbapenem-resistant Gram-negative bacteria from routinely collected data. International Congress on Infectious Diseases (ICID), Hyderabad, India, 2-5 March 2016.

Batten L, Holmes A, Otter JA*, Castro-Sanchez E. Estimating the isolation burden if overseas residents are pre-emptively isolated during CRE admission screening. Infection Prevention Society (IPS) Annual Meeting. Liverpool, UK, 28-30 September 2015.

Mookerjee S, Sullivan J, Davies F, Donaldson H, Brannigan E, Holmes A, Otter JA*. Real-time surveillance of carbapenem-resistant Enterobacteriaceae (CRE) using live microbiology culture data in a North-West London Hospital Trust, 2014–2015. Infection Prevention Society (IPS) Annual Meeting. Liverpool, UK, 28-30 September 2015.

Alexander M, Mookerjee S, Nelson D, Holmes A, Otter JA*An audit of single room capacity for isolation at a London hospital Trust. Infection Prevention Society (IPS) Annual Meeting. Liverpool, UK, 28-30 September 2015.

Galletly T, Bateman A, Brannigan E, Holmes A, Otter JA*. Thematic analysis of post 48-hour bloodstream infections: What did we learn? Infection Prevention Society (IPS) Annual Meeting. Liverpool, UK, 28-30 September 2015.

Acharya A , Samarasinghe D , Singleton J, Brannigan E, Galletly T, Donaldson H, Holmes A, Otter JA*. Pilot evaluation of environmental hygiene using fluorescent markers and microbiological cultures. Infection Prevention Society (IPS) Annual Meeting. Liverpool, UK, 28-30 September 2015.

Gilchrist M , Galletly T, Brannigan E, Holmes A, Otter JA*. How much Clostridium difficile is preventable? Infection Prevention Society (IPS) Annual Meeting. Liverpool, UK, 28-30 September 2015.

Goldberg S, Dyakova E, Bisnauthsing K, Querol-Rubiera A, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth J, Otter JA*. Poor sensitivity of perineal compared with rectal swabs for detecting ESBL Enterobacteriaceae. Infection Prevention Society (IPS) Annual Meeting. Liverpool, UK, 28-30 September 2015.

Otter JA, Bisnauthsing K, Querol-Rubiera A, Walker C, Ahanonu C, Patel A, Tosas Auguet Olga, Edgeworth J, Goldenberg SD*. Universal admission screening for CRE using PCR detects 14-fold more carriers than agar-based methods at a London hospital. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, Denmark, April 2015.

Biswas J, Patel A, Otter JA, Wade P, Newsholme W, Goldenberg SD*. Reduction in Clostridium difficile environmental contamination in hospitalised patients treated with fidaxomicin. Healthcare Infection Society (HIS) Conference, Lyon, France, 16-18 November 2014.

O’Halloran P, Otter JA*, Adams NMT, Chewins J. Evaluating the reduction in wound bioburden using aqueous oxygen peroxide technology. Healthcare Infection Society (HIS) Conference, Lyon, France, 16-18 November 2014.

Otter JA*, Mepham S, Athan B, Mack D, Smith R, Jacobs M, Hopkins S. Terminal decontamination of the Royal Free London High Level Isolation Unit (HLIU) following a case of Ebola virus disease using hydrogen peroxide vapour. Healthcare Infection Society (HIS) Conference, Lyon, France, 16-18 November 2014.

Lemmen S, Scheithauer S, Häfner H, Yezli S, Mohr M, Otter JA*. Evaluation of hydrogen peroxide vapour for the inactivation of nosocomial pathogens on porous and non-porous surfaces. Healthcare Infection Society (HIS) Conference, Lyon, France, 16-18 November 2014.

Otter JA*, Tucker D. Does converting a ward to single rooms reduce rates of infection? A systematic review. Infection Prevention Society (IPS) Annual Meeting, Glasgow, Scotland, 29 September – 1 October 2014.

Otter JA*, Donskey C, Weber D. How long do SARS and MERS coronaviruses, and influenza survive on dry surfaces. Infection Prevention Society (IPS) Annual Meeting, Glasgow, Scotland, 29 September – 1 October 2014.

Kearns AM, Vickers A, Pichon B, Ganner M, Johnson A, Charlett A, Hill R on behalf of the Community Skin Infection (CSI) Study Group. Community staphylococcal pyogenic skin infections in England: PVL, MRSA & clonal diversity. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Barcelona, Spain, 10-13 May 2014.

Boakes E, Marbach H, Lynham S, Ward M, Edgeworth JD, Otter JA*. Community-associated MRSA strains are no more virulent than healthcare-associated MRSA strains in a range of laboratory assays. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Barcelona, Spain, 10-13 May 2014.

Hughes J*, Goldenberg SD, Tosas O, Edgeworth JD, Otter JA. Recent emergence of carbapenem-resistant organisms in a low prevalence UK setting in London. Federation of Infection Sciences (FIS), Birmingham, UK, 11-13 November 2013.

Havill NL, Boyce JM, Otter JA*. Extended survival of carbapenem-resistant Enterobacteriaceae (CRE) on dry surfaces. ID Week, San Francisco, California, USA, 2-6 October 2013.

Tucker D, Chappell J, Millward L, Otter JA*. An overview of hydrogen peroxide vapour (HPV) room disinfection at a London Hospital, 2011-2013. Infection Prevention Society (IPS) Annual Meeting. London, UK, 30 September – 1 October 2013.

Yezli S*, Bissell D, Otter JA. The Infection Control Enclosure (ICE)-pod: meeting the need for more single rooms. Asia Pacific Society of Infection Control, Shanghai, China, 10-13 April 2013.

O’Halloran P*, Winter P, Chewins J, Otter JA. Randomised, double-blind, placebo controlled trial of aqueous oxygen peroxide (AOP) in the treatment of venous leg ulcers in a primary care based setting. Wounds UK Annual Conference. Harrogate, UK, 2012.

Passaretti CL, Otter JA*, Reich NG, Myers J, Shepard J, Ross T, Carroll KC, Lipsett P, Perl TM. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. 8th International Healthcare Infection Society (HIS) Conference and Federation of Infection Societies (FIS) Annual Conference. Liverpool, UK, 19-21 November 2012.

Virata MD, Otter JA*, Havill NL, Monecke S, Sakoulas G. DNA microarray-based genotyping of methicillin-resistant Staphylococcus aureus isolates in patients with bacteremia and evidence of antimicrobial resistance from 1998-2008. ID Week, San Diego, USA, 17-21 October 2012. Poster 392.

Otter JA*, Nowakowski E, Salkeld JAG, Duclos M, Yezli S, Passaretti CL, Ross T, Carroll KC, Perl TM. Decontamination of unused medical supply packaging using hydrogen peroxide vapour. Infection Prevention Society (IPS) Annual Meeting. Liverpool, UK, 1-3 October 2012. Abstract 81.

Virata MD*, Otter JA, Havill NL, Sakoulas G. Comparing Staphylococcus aureus staphyloxanthin pigment production among bloodstream isolates with vancomycin MICs and clone type from a community hospital. American Society for Microbiology (ASM), San Francisco, California, USA. June 2012.

Boakes E, Marbach H, Lynham S, Ward M, Edgeworth JD, Otter JA*. Production of phenol soluble modulins by community- and hospital-associated MRSA strains correlates with in vivo virulence in a Galleria mellonella (caterpillar) model. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), London, UK. 31 March – 3 April 2012.

Otter JA*, Havill NL, Virata MD. Vancomycin MIC and clone type are independent predictors of persistent MRSA bacteraemia at a USA hospital. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), London, UK. 31 March – 3 April 2012.

Otter JA*, Goyal S, Chander Y, Yezli S. Hydrogen peroxide vapour (HPV) inactivation of feline calicivirus, a surrogate for norovirus: an update. Infection Prevention Society (IPS) Annual Meeting. Bournemouth, 19-21 September 2011. Abstract 57.

Otter JA*, Murdoch L, Stone J. Successful reduction in the burden of C. difficile at a large NHS Trust through a bundle of interventions. Infection Prevention Society (IPS) Annual Meeting. Bournemouth, 19-21 September 2011. Abstract 57.

Miller C*, Tosas O, Batra R, Otter JA, French GL, Edgeworth JD. An interaction between clone type and vancomycin MIC influence risk of endocarditis associated with MRSA bloodstream infection. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Milan, Italy, 7-10 May 2011.

Otter JA*, Edgeworth J, Miller C, French GL. The changing molecular epidemiology of methicillin-resistant Staphylococcus aureus bacteraemia at a London teaching hospital, 1999-2009. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Milan, Italy, 7-10 May 2011.

Barbut F. Pham J, Yezli S, Mimoun M, Otter JA*. Reducing the spread of Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus on a burns unit through the intervention of an infection control bundle including hydrogen peroxide vapour decontamination. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Milan, Italy, 7-10 May 2011.

Barbut F, Yezli S, Otter JA*. The in vitro activity of hydrogen peroxide vapour against epidemic strains of Clostridium difficile spores. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Milan, Italy, 7-10 May 2011.

Goyal SM, Chander Y, Yezli S, Otter JA*. Hydrogen peroxide vapor (HPV) inactivation of feline calicivirus, a surrogate for norovirus. J Hosp Infect 2010:76 (Suppl. 1);S22-S23. (Hospital Infection Society (HIS), 10-13 October 2010, P08.02, Liverpool, UK).

Otter JA*, Barnicoat M, Down J, Smyth D, Yezli S, Jeanes A. Hydrogen peroxide vapor (HPV) decontamination of an intensive care unit room used to treat a patient with Lassa fever. J Hosp Infect 2010:76 (Suppl. 1);S23. (Hospital Infection Society (HIS), 10-13 October 2010, P08.04, Liverpool, UK).

Otter JA, Yezli S, Bissell D*. Hydrogen peroxide vapour (HPV) decontamination: a novel technology for the control of hospital acquired infections. Australian Infection Control Association Conference, 4-6 October 2010, Perth, Australia.

Adams NMT*, Yezli S, Otter JA. Hydrogen peroxide vapour decontamination: a versatile method to tackle biological warfare agents and pathogens associated with hospital-acquired infections. International Symposium on Protection Against Chemical and Biological Warefare Agents, 8-11 June 2010, Stockholm, Sweden.

Yezli S, Millward L, Salkeld JAG, Parks MJ, Otter JA*. Routine use of hydrogen peroxide vapour decontamination in the NHS. Infection Prevention Society (IPS) Annual Meeting. Harrogate, 2009. Abstract 15.

Otter JA*, French GL. Validation of antimicrobial resistance based phenotypic markers for the presumptive identification of community-associated MRSA at a London Teaching Hospital. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Francisco, CA, USA, 2009. [Poster*] (14th International Symposium on Staphylococci and Staphylococcal Infection (ISSSI), Bath, UK, September 2010.)

Passaretti CL*­, Otter JA, Lipsett P, Shangraw A, Myers J, Ross T, Carroll K, Perl TM. Adherence to Hydrogen Peroxide Vapor (HPV) decontamination reduces VRE acquisition in high-risk units. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Diseases Society of America (IDSA). Washington DC, USA, 2008. Abstract K4124b.

Passaretti CL­*, Lipsett P, Otter JA, Speck K, Lee A, Ryan D, Salkeld JAG, Adams NMT, Ristaino P, Maragakis L, Ross T, Carroll K, Perl TM. Does hydrogen peroxide vapor (HPV) enhance decontamination for multidrug-resistant organisms (MDROs) in intensive care units (ICUs)? Society for Healthcare Epidemiology of America (SHEA), Orlando, Florida, 2008. Abstract 177.

Puchowicz M, Ryan D, Otter JA*, Salkeld JAG, Cooper TA, Havill NL, Tuozzo K, Boyce JM. Feasibility of ongoing use of hydrogen peroxide vapor (HPV) technology to decontaminate rooms vacated by patients with multidrug-resistant organisms. Society for Healthcare Epidemiology of America (SHEA), Orlando, Florida, 2008.

Dryden M, Parnaby R, Dailly S, Lewis T, Davis-Blues K, Otter JA*, Kearns AM. Environmental decontamination with hydrogen peroxide vapor (HPV) in the control of an MRSA outbreak. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2007, Chicago.

Otter JA*, Klein J, Watts T, Kearns AM, French GL. P1324. Control of an outbreak of an unusual ciprofioxacin-susceptible variant of methicillin-resistant Staphylococcus aureus EMRSA-15 on a neonatal unit. Int J Antimicrob Agents 2007;29 Suppl. 2:S366. (European Congress of Clinical Microbiology and Infectious Disease (ECCMID)).

Otter JA*, French GL. P1587 The molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital. Int J Antimicrob Agents 2007;29 Suppl. 2:S445-446. (European Congress of Clinical Microbiology and Infectious Disease (ECCMID)).

Schouten M, Otter JA*, van Zanten A, Houmes-Zielman G, Nohlmans-Paulssen M. P1692 Environmental decontamination of an intensive care unit to control outbreaks of multidrug-resistant Gram-negative rods using hydrogen peroxide vapour. Int J Antimicrob Agents 2007;29 Suppl. 2:S479. (European Congress of Clinical Microbiology and Infectious Disease (ECCMID)).

Hall L*, Otter JA, Chewins J, Wengenack NL. Use of hydrogen peroxide vapour for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. American Society for Microbiology (ASM), Orlando, Florida, 2006.

Hall L*, Otter JA, Chewins J, Wengenack NL. Deactivation of dimorphic fungi using HPV. International Society of Human and Animal Mycology (ISHAM), Paris, France, 2006.

French GL, Shannon KP, Otter JA*. Survival of nosocomial bacteria dried in air and killing by hydrogen peroxide vapour (HPV). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington DC, 2004.

Advertisements